These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36270494)

  • 21. Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study.
    Seo WW; Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    BMJ Open; 2020 Feb; 10(2):e030514. PubMed ID: 32034017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF).
    Ghazi L; Desai NR; Simonov M; Yamamoto Y; O'Connor KD; Riello RJ; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Ahmad T
    Am Heart J; 2022 Feb; 244():107-115. PubMed ID: 34808104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
    Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.
    Mazza A; Townsend DM; Torin G; Schiavon L; Camerotto A; Rigatelli G; Cuppini S; Minuz P; Rubello D
    Biomed Pharmacother; 2020 Oct; 130():110596. PubMed ID: 34321170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair.
    Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Brachtendorf BM; Horn P; Zachoval C; Sugiura A; Kelm M; Baldus S; Nickenig G; Westenfeld R; Pfister R; Becher MU
    Heart; 2022 Oct; 108(21):1722-1728. PubMed ID: 35672114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Higuchi S; Orban M; Adamo M; Giannini C; Melica B; Karam N; Praz F; Kalbacher D; Koell B; Stolz L; Braun D; Näbauer M; Wild M; Doldi P; Neuss M; Butter C; Kassar M; Ruf T; Petrescu A; Ludwig S; Pfister R; Iliadis C; Unterhuber M; Sampaio F; Ferreira D; Thiele H; Baldus S; von Bardeleben RS; Massberg S; Windecker S; Lurz P; Petronio AS; Lindenfeld J; Abraham WT; Metra M; Hausleiter J;
    Eur J Heart Fail; 2022 Nov; 24(11):2152-2161. PubMed ID: 35791663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
    Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction.
    Wongsalap Y; Poolpun D; Keawhai K; Kitpluem N; Pansiri P; Malaimat S; Senthong V; Kengkla K
    Chronic Dis Transl Med; 2023 Jun; 9(2):154-163. PubMed ID: 37305111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right ventricular dysfunction in patients with new-onset heart failure: longitudinal follow-up during guideline-directed medical therapy.
    Ansari Ramandi MM; van Melle JP; Gorter TM; Hoendermis ES; van Veldhuisen DJ; Nauta JF; van der Wal MHL; Warink-Riemersma J; Voors AA; Dickinson MG
    Eur J Heart Fail; 2022 Dec; 24(12):2226-2234. PubMed ID: 36250250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic Modeling Analysis of an Intensive GDMT Optimization Program in Hospitalized Heart Failure Patients.
    Dixit NM; Parikh NU; Ziaeian B; Fonarow GC
    Circ Heart Fail; 2023 Dec; 16(12):e011218. PubMed ID: 37929591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Desai AS; Maclean T; Blood AJ; Bosque-Hamilton J; Dunning J; Fischer C; Fera L; Smith KV; Wagholikar K; Zelle D; Gaziano T; Plutzky J; Scirica B; MacRae CA
    JAMA Cardiol; 2020 Dec; 5(12):1430-1434. PubMed ID: 32936209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).
    Jin X; Cao J; Zhou J; Wang Y; Han X; Song Y; Fan Y; Chen Z; Xu D; Yang X; Dong W; Li L; Chen L; Zhong Q; Fu M; Hu K; Zhou J; Ge J;
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100415. PubMed ID: 31508483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival.
    Akita K; Kohno T; Kohsaka S; Shiraishi Y; Nagatomo Y; Izumi Y; Goda A; Mizuno A; Sawano M; Inohara T; Fukuda K; Yoshikawa T;
    Int J Cardiol; 2017 May; 235():162-168. PubMed ID: 28259550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients.
    Wang N; Evans J; Sawant S; Sindone J; Lal S
    Heart Fail Rev; 2023 Jul; 28(4):949-959. PubMed ID: 36198840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients　- A Report From the West Tokyo Heart Failure Registry.
    Ohata T; Niimi N; Shiraishi Y; Nakatsu F; Umemura I; Kohno T; Nagatomo Y; Takei M; Ono T; Sakamoto M; Nakano S; Fukuda K; Kohsaka S; Yoshikawa T
    Circ J; 2023 Dec; 88(1):22-30. PubMed ID: 37914282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients.
    Matsukawa R; Okahara A; Tokutome M; Itonaga J; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Kawai S; Ogawa K; Matsuura H; Mukai Y
    ESC Heart Fail; 2023 Dec; 10(6):3352-3363. PubMed ID: 37671603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.